{"id":"https://openalex.org/W2895816045","doi":"https://doi.org/10.1186/s13195-018-0431-6","title":"Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer\u2019s disease: results of a randomized, double-blind, placebo-controlled phase 2a study","display_name":"Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer\u2019s disease: results of a randomized, double-blind, placebo-controlled phase 2a study","publication_year":2018,"publication_date":"2018-10-11","ids":{"openalex":"https://openalex.org/W2895816045","doi":"https://doi.org/10.1186/s13195-018-0431-6","mag":"2895816045","pmid":"https://pubmed.ncbi.nlm.nih.gov/30309389","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6182869"},"language":"en","primary_location":{"id":"doi:10.1186/s13195-018-0431-6","doi":"https://doi.org/10.1186/s13195-018-0431-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13195-018-0431-6","pdf_url":"https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-018-0431-6","source":{"id":"https://openalex.org/S140755874","display_name":"Alzheimer s Research & Therapy","issn_l":"1758-9193","issn":["1758-9193"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's Research & Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-018-0431-6","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025870220","display_name":"Philip Scheltens","orcid":"https://orcid.org/0000-0002-1046-6408","observed_orcids":["https://orcid.org/0000-0002-1046-6408"]},"institutions":[{"id":"https://openalex.org/I4210108594","display_name":"Amsterdam Neuroscience","ror":"https://ror.org/01x2d9f70","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210108594"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Philip Scheltens","raw_affiliation_strings":["Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands. p.scheltens@vumc.nl","Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-1046-6408","affiliations":[{"raw_affiliation_string":"Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands. p.scheltens@vumc.nl","institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108594486","display_name":"Merja Hallikainen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I175532246","display_name":"University of Eastern Finland","ror":"https://ror.org/00cyydd11","country_code":"FI","type":"education","lineage":["https://openalex.org/I175532246"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Merja Hallikainen","raw_affiliation_strings":["University of Eastern Finland, Institute of Clinical Medicine, Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Eastern Finland, Institute of Clinical Medicine, Kuopio, Finland","institution_ids":["https://openalex.org/I175532246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020478194","display_name":"Timo Grimmer","orcid":"https://orcid.org/0000-0002-6829-6253","observed_orcids":["https://orcid.org/0000-0002-6829-6253"]},"institutions":[{"id":"https://openalex.org/I2802619606","display_name":"TUM Klinikum","ror":"https://ror.org/04jc43x05","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]},{"id":"https://openalex.org/I62916508","display_name":"Technical University of Munich","ror":"https://ror.org/02kkvpp62","country_code":"DE","type":"education","lineage":["https://openalex.org/I62916508"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Timo Grimmer","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany","institution_ids":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004951090","display_name":"Thomas Duning","orcid":"https://orcid.org/0000-0003-3942-0697","observed_orcids":["https://orcid.org/0000-0003-3942-0697"]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Duning","raw_affiliation_strings":["Department of Neurology, University of M\u00fcnster, M\u00fcnster, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of M\u00fcnster, M\u00fcnster, Germany","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066482735","display_name":"Alida A. Gouw","orcid":"https://orcid.org/0000-0003-1481-3881","observed_orcids":["https://orcid.org/0000-0003-1481-3881"]},"institutions":[{"id":"https://openalex.org/I4210108594","display_name":"Amsterdam Neuroscience","ror":"https://ror.org/01x2d9f70","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210108594"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Alida A Gouw","raw_affiliation_strings":["Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","Department of Clinical Neurophysiology and MEG Center, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Clinical Neurophysiology and MEG Center, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075394738","display_name":"Charlotte Elisabeth Teunissen","orcid":"https://orcid.org/0000-0002-4061-0837","observed_orcids":["https://orcid.org/0000-0002-4061-0837"]},"institutions":[{"id":"https://openalex.org/I4210108594","display_name":"Amsterdam Neuroscience","ror":"https://ror.org/01x2d9f70","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210108594"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Charlotte E Teunissen","raw_affiliation_strings":["Department of Clinical Chemistry, Neurochemistry Laboratory and Biobank, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Neurochemistry Laboratory and Biobank, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073162343","display_name":"Alle Meije Wink","orcid":"https://orcid.org/0000-0002-8197-0118","observed_orcids":["https://orcid.org/0000-0002-8197-0118"]},"institutions":[{"id":"https://openalex.org/I4210108594","display_name":"Amsterdam Neuroscience","ror":"https://ror.org/01x2d9f70","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210108594"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Alle Meije Wink","raw_affiliation_strings":["Department of Radiology, Nuclear Medicine and PET Research, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Nuclear Medicine and PET Research, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064879007","display_name":"Paul T. Maruff","orcid":"https://orcid.org/0000-0002-6947-9537","observed_orcids":["https://orcid.org/0000-0002-6947-9537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Maruff","raw_affiliation_strings":["Cogstate Ltd, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cogstate Ltd, Melbourne, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055702421","display_name":"John Harrison","orcid":"https://orcid.org/0000-0002-0225-4923","observed_orcids":["https://orcid.org/0000-0002-0225-4923"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4210108594","display_name":"Amsterdam Neuroscience","ror":"https://ror.org/01x2d9f70","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210108594"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["GB","NL"],"is_corresponding":false,"raw_author_name":"John Harrison","raw_affiliation_strings":["Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068393433","display_name":"Caroline G. C. M. van Baal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Caroline M van Baal","raw_affiliation_strings":["Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090972750","display_name":"Suzanne Bruins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144058","display_name":"Probiodrug (Germany)","ror":"https://ror.org/03p4y9t51","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210144058"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Suzanne Bruins","raw_affiliation_strings":["Probiodrug AG, Halle, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probiodrug AG, Halle, Germany","institution_ids":["https://openalex.org/I4210144058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112007704","display_name":"Inge Lues","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144058","display_name":"Probiodrug (Germany)","ror":"https://ror.org/03p4y9t51","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210144058"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Inge Lues","raw_affiliation_strings":["Probiodrug AG, Halle, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probiodrug AG, Halle, Germany","institution_ids":["https://openalex.org/I4210144058"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039252548","display_name":"Niels D. Prins","orcid":"https://orcid.org/0000-0002-6297-7592","observed_orcids":["https://orcid.org/0000-0002-6297-7592"]},"institutions":[{"id":"https://openalex.org/I4210108594","display_name":"Amsterdam Neuroscience","ror":"https://ror.org/01x2d9f70","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210108594"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Niels D Prins","raw_affiliation_strings":["Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","Brain Research Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Brain Research Center, Amsterdam, The Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5025870220"],"corresponding_institution_ids":["https://openalex.org/I4210108594","https://openalex.org/I911458345"],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":{"value":4290,"currency":"USD","value_usd":4290},"fwci":4.4978,"has_fulltext":true,"cited_by_count":134,"citation_normalized_percentile":{"value":0.96559647,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"10","issue":"1","first_page":"107","last_page":"107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/synaptic-dysfunction","display_name":"synaptic dysfunction","score":0.8379999995231628},{"id":"https://openalex.org/keywords/mild-cognitive-impairment","display_name":"mild cognitive impairment","score":0.8330000042915344},{"id":"https://openalex.org/keywords/mild-dementia","display_name":"mild dementia","score":0.9190000295639038},{"id":"https://openalex.org/keywords/eeg-theta-power","display_name":"EEG theta power","score":0.7950000166893005},{"id":"https://openalex.org/keywords/neurogranin","display_name":"neurogranin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/ykl-40","display_name":"YKL-40","score":0.9900000095367432},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.7990000247955322},{"id":"https://openalex.org/keywords/target-occupancy","display_name":"target occupancy","score":0.4819999933242798},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7129999995231628},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-biomarkers","display_name":"cerebrospinal fluid biomarkers","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9611899256706238},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7159830331802368},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6832725405693054},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5907517671585083},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.548311173915863},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49096158146858215},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4902956783771515},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.47156187891960144},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3341900110244751},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.23969817161560059},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09818229079246521},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048288","descriptor_name":"Imidazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":12,"locations":[{"id":"doi:10.1186/s13195-018-0431-6","doi":"https://doi.org/10.1186/s13195-018-0431-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13195-018-0431-6","pdf_url":"https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-018-0431-6","source":{"id":"https://openalex.org/S140755874","display_name":"Alzheimer s Research & Therapy","issn_l":"1758-9193","issn":["1758-9193"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's Research & Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5136995","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6182869","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:30309389","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30309389","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's research & therapy","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:6182869","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6182869/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimers Res Ther","raw_type":"Text"},{"id":"pmh:oai:erepo.uef.fi:123456789/7074","doi":null,"is_oa":true,"landing_page_url":"https://erepo.uef.fi/handle/123456789/7074","pdf_url":"https://erepo.uef.fi/bitstreams/1c5669f2-51e5-422d-a7b1-ae1429e4099a/download","source":{"id":"https://openalex.org/S4306402418","display_name":"UEF eRepo (University of Eastern Finland)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I175532246","host_organization_name":"University of Eastern Finland","host_organization_lineage":["https://openalex.org/I175532246"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/249628","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11343/249628","pdf_url":"http://hdl.handle.net/11343/249628","source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/f4922882-26c6-4521-b848-b9149d169b82","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/files/158933522/Safety-tolerability-and-efficacy-of-the-glutaminyl-cyclase-inhibitor-pq912-in-alzheimers-disease-results-of-a-randomi.pdf","pdf_url":"https://pure.amsterdamumc.nl/ws/files/158933522/Safety-tolerability-and-efficacy-of-the-glutaminyl-cyclase-inhibitor-pq912-in-alzheimers-disease-results-of-a-randomi.pdf","source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scheltens, P, Hallikainen, M, Grimmer, T, Duning, T, Gouw, A A, Teunissen, C E, Wink, A M, Maruff, P, Harrison, J, van Baal, C M, Bruins, S, Lues, I & Prins, N D 2018, 'Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: Results of a randomized, double-blind, placebo-controlled phase 2a study', Alzheimer's Research and Therapy, vol. 10, no. 1, 107. https://doi.org/10.1186/s13195-018-0431-6","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:691f429b58a244929af4927237eedec1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/691f429b58a244929af4927237eedec1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alzheimer\u2019s Research & Therapy, Vol 10, Iss 1, Pp 1-14 (2018)","raw_type":"article"},{"id":"pmh:oai:mediatum.ub.tum.de:node/1481828","doi":null,"is_oa":false,"landing_page_url":"https://mediatum.ub.tum.de/1481828","pdf_url":null,"source":{"id":"https://openalex.org/S4306400453","display_name":"mediaTUM \u2013 the media and publications repository of the Technical University Munich (Technical University Munich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I62916508","host_organization_name":"Technical University of Munich","host_organization_lineage":["https://openalex.org/I62916508"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"pmh:oai:pure.atira.dk:openaire/158ca63b-f363-4d82-9f53-7563d5f669b7","doi":null,"is_oa":true,"landing_page_url":"https://www.scopus.com/pages/publications/85054757078","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scheltens, P, Hallikainen, M, Grimmer, T, Duning, T, Gouw, A A, Teunissen, C E, Wink, A M, Maruff, P, Harrison, J, van Baal, C M, Bruins, S, Lues, I & Prins, N D 2018, 'Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: Results of a randomized, double-blind, placebo-controlled phase 2a study', Alzheimer's Research and Therapy, vol. 10, no. 1, 107. https://doi.org/10.1186/s13195-018-0431-6","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/158ca63b-f363-4d82-9f53-7563d5f669b7","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/158ca63b-f363-4d82-9f53-7563d5f669b7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alzheimer's Research and Therapy, 10(1):107. BioMed Central","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:3210997868","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902249195236574","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1186/s13195-018-0431-6","doi":"https://doi.org/10.1186/s13195-018-0431-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13195-018-0431-6","pdf_url":"https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-018-0431-6","source":{"id":"https://openalex.org/S140755874","display_name":"Alzheimer s Research & Therapy","issn_l":"1758-9193","issn":["1758-9193"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's Research & Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2895816045.pdf","grobid_xml":"https://content.openalex.org/works/W2895816045.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1497201830","https://openalex.org/W1520284233","https://openalex.org/W1973705647","https://openalex.org/W1974145718","https://openalex.org/W1978116973","https://openalex.org/W1978635035","https://openalex.org/W1987387046","https://openalex.org/W2015153982","https://openalex.org/W2034211658","https://openalex.org/W2051804431","https://openalex.org/W2064984531","https://openalex.org/W2081051305","https://openalex.org/W2082429191","https://openalex.org/W2087243986","https://openalex.org/W2090468415","https://openalex.org/W2109582949","https://openalex.org/W2111200377","https://openalex.org/W2115017507","https://openalex.org/W2134711807","https://openalex.org/W2148155494","https://openalex.org/W2149862198","https://openalex.org/W2151393950","https://openalex.org/W2167840686","https://openalex.org/W2168334242","https://openalex.org/W2192963340","https://openalex.org/W2205427262","https://openalex.org/W2257675936","https://openalex.org/W2313952418","https://openalex.org/W2327547544","https://openalex.org/W2412168215","https://openalex.org/W2535282315","https://openalex.org/W2582524520","https://openalex.org/W2606113932","https://openalex.org/W2609307726","https://openalex.org/W2621288092","https://openalex.org/W3014251530","https://openalex.org/W4210975612","https://openalex.org/W4313635404"],"related_works":["https://openalex.org/W7052540796","https://openalex.org/W6977321244","https://openalex.org/W2192963340","https://openalex.org/W6939744093","https://openalex.org/W2485000086","https://openalex.org/W2609307726","https://openalex.org/W1993324769","https://openalex.org/W3137331428","https://openalex.org/W1982724245","https://openalex.org/W2897925330"],"abstract_inverted_index":{"BACKGROUND:":[0],"PQ912":[1,30,104,184,276,285,300,385],"is":[2],"an":[3,314],"inhibitor":[4],"of":[5,18,103,134,162,201,235,257,318,324,341,361,384,421],"the":[6,16,25,43,61,98,132,135,199,217,236,255,275,328,337,374,390,418],"glutaminyl":[7,308],"cyclase":[8,309],"enzyme":[9],"that":[10],"plays":[11],"a":[12,92,149,270,304,333,359,404],"central":[13],"role":[14],"in":[15,31,113,141,254,274,303,307,313,327,336,373,425],"formation":[17],"synaptotoxic":[19],"pyroglutamate-A-beta":[20],"oligomers.":[21],"We":[22],"report":[23],"on":[24,71,198,213,435],"first":[26],"clinical":[27],"study":[28,237],"with":[29,33,64,115,164,259,269,284],"subjects":[32,114,128,228,258,282],"biomarker-proven":[34],"Alzheimer's":[35],"disease":[36],"(AD).":[37],"The":[38,53,67,125,187,348,380],"aim":[39],"was":[40,91,248,346],"to":[41,60,123,171,182,192,206,222,279,289,294,364,368,408,416],"determine":[42],"maximal":[44,381],"tolerated":[45,382],"dose,":[46],"target":[47,316,402],"occupancy":[48,317],"and":[49,85,101,147,157,195,211,296,332,356,389,412],"treatment-related":[50],"pharmacodynamic":[51],"effects.":[52],"exploratory":[54,349],"efficacy":[55,102,371,422],"readouts":[56],"selected":[57],"were":[58,129,169,179,191,241,265],"tailored":[59],"patient":[62],"population":[63],"early":[65,419],"AD.":[66,124],"therapeutic":[68],"approach":[69],"focuses":[70],"synaptic":[72,83,354],"dysfunction":[73],"as":[74,80,358,370,423],"captured":[75],"by":[76],"various":[77],"measures":[78],"such":[79],"electroencephalography":[81],"(EEG),":[82],"biomarkers":[84,140],"sensitive":[86,366],"cognitive":[87,117],"tests.":[88],"METHODS:":[89],"This":[90],"randomized,":[93],"double-blind,":[94],"placebo-controlled":[95],"trial":[96],"evaluating":[97],"safety,":[99],"tolerability":[100,196],"800":[105,172],"mg":[106,166,173],"twice":[107],"daily":[108],"(bid)":[109],"for":[110,175,243,353],"12":[111],"weeks":[112],"mild":[116,120],"impairment":[118],"or":[119,185,239],"dementia":[121],"due":[122,205,288],"120":[126],"enrolled":[127],"treatment-na\u00efve":[130],"at":[131,145,231,395],"start":[133],"study,":[136],"had":[137,148],"confirmed":[138],"AD":[139],"their":[142],"cerebrospinal":[143],"fluid":[144],"screening":[146],"Mini":[150],"Mental":[151],"State":[152],"Examination":[153],"score":[154],"between":[155,252],"21":[156],"30.":[158],"After":[159],"1":[160],"week":[161],"treatment":[163,218,224,238,287,301,414],"400":[165],"bid,":[167],"patients":[168,202,268],"up-titrated":[170],"bid":[174],"11":[176],"weeks.":[177],"Patients":[178],"randomized":[180,223,227],"1:1":[181],"either":[183],"placebo.":[186,280],"primary":[188],"composite":[189],"endpoints":[190],"assess":[193],"safety":[194,244],"based":[197,212],"number":[200,256],"who":[203,229],"discontinued":[204,286],"(serious)":[207,260],"adverse":[208,261,272,290],"events":[209],"(safety),":[210],"dose":[214,234,383],"adjustment":[215],"during":[216],"period":[219],"and/or":[220],"nonadherence":[221],"(tolerability).":[225],"All":[226],"took":[230],"least":[232],"one":[233],"placebo":[240],"used":[242],"analyses.":[245],"RESULTS:":[246],"There":[247],"no":[249],"significant":[250,305,322,334],"difference":[251],"treatments":[253],"events,":[262,291],"although":[263],"there":[264],"slightly":[266],"more":[267],"serious":[271],"event":[273],"group":[277],"compared":[278],"More":[281],"treated":[283],"mostly":[292],"related":[293],"gastrointestinal":[295],"skin/subcutaneous":[297],"tissue":[298],"disorders.":[299],"resulted":[302,312],"reduction":[306,323],"activity,":[310],"which":[311],"average":[315],">":[319,400],"90%.":[320],"A":[321],"theta":[325],"power":[326],"EEG":[329],"frequency":[330],"analysis":[331],"improvement":[335],"One":[338],"Back":[339],"test":[340],"our":[342],"Neuropsychological":[343],"Test":[344],"Battery":[345],"observed.":[347],"biomarker":[350],"readouts,":[351],"neurogranin":[352],"toxicity":[355],"YKL-40":[357],"marker":[360],"inflammation,":[362],"appear":[363],"be":[365],"enough":[367],"serve":[369],"markers":[372],"next":[375],"phase":[376,407],"2b":[377],"study.":[378,427],"CONCLUSIONS:":[379],"has":[386],"been":[387],"identified":[388],"results":[391],"support":[392],"future":[393],"studies":[394],"still":[396],"lower":[397],"doses":[398],"reaching":[399],"50%":[401],"occupancy,":[403],"longer":[405,413],"up-titration":[406],"potentially":[409],"induce":[410],"adaptation":[411],"periods":[415],"confirm":[417],"signals":[420],"seen":[424],"this":[426],"TRIAL":[428],"REGISTRATION:":[429],"Clinicaltrials.gov,":[430],"NCT":[431],"02389413":[432],".":[433],"Registered":[434],"17":[436],"March":[437],"2015.":[438]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-10-26T00:00:00"}